Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02335710 · ClinicalTrials.gov registry record
Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions
A clinical trial, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- 50
- Enrollment target
NCT02335710: Completed study, sponsored by The University of Tennessee, Knoxville.
NCT02335710 is a clinical trial that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02335710 has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Smith \& Nephew's first edition of the Journey posterior stabilizing total knee arthroplasty was analyzed by the Center for Musculoskeletal Research in a past research study, and it was determined that subjects experienced more normal-like kinematic patterns. They also achieved excessive axial rotation and a decrease in weight-bearing knee flexion. Since Smith \& Nephew has made modifications to the Journey bi-cruciate stabilizing (BCS) total knee arthroplasty (TKA) design, researchers will again evaluate the kinematics of subjects implanted with the revised design to determine if subjects experience normal-like kinematic patterns and if greater weight-bearing knee flexion is achieved. The objective for this study is to analyze the in vivo kinematics for subjects implanted with a 2nd generation Journey BCS TKA and compare those patterns to subjects having a normal knee and those having the 1st generation Journey posterior stabilizing (PS) TKA that were analyzed in the previous study.
Primary Outcome
Anterior Posterior (AP) translations of medial femoral condyles during DKB Anterior Posterior (AP) translations of lateral femoral condyles during DKB
Interventions
- DEVICE Journey II BCS TKA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-07 |
What the finished NCT02335710 record still lists
NCT02335710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Journey II BCS TKA is the first listed.
NCT02335710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02335710 about?
NCT02335710 is a clinical study titled "Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions". Smith \& Nephew's first edition of the Journey posterior stabilizing total knee arthroplasty was analyzed by the Center for Musculoskeletal Research in a past research study, and it was determined that subjects experienced more normal-like kinematic patterns. They also achieved excessive axial rotat...
What is the current status of trial NCT02335710?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02335710?
The interventions under investigation include: Journey II BCS TKA (DEVICE).
Who is sponsoring clinical trial NCT02335710?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia